Literature DB >> 11954886

Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis.

L S Ou1, L C See, C J Wu, C C Kao, Y L Lin, J L Huang.   

Abstract

Circulating interleukin-1beta (IL-1beta), IL-6, tumour necrosis factor-alpha (TNF-alpha), osteocalcin, and conventional parameters of inflammation were examined serially in 14 children with juvenile idiopathic arthritis (JIA) to determine any correlation with the disease activity. Serum IL-1beta was undetectable in all JIA patients. Serum IL-6, white blood cell counts, platelet counts, erythrocyte sedimentation rate and C-reactive protein levels were significantly elevated in the active phase of JIA, whereas hemoglobin levels were significantly lower. Osteocalcin levels were decreased and TNF-alpha increased in active JIA status, but these differences showed no statistical significance. We concluded that inflammatory cytokines play an important role in JIA. Monitoring IL-6 in children with JIA is useful in determining disease activity and response to therapy. These findings confirm earlier reports.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11954886     DOI: 10.1007/s100670200012

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

Review 2.  The use of anakinra in juvenile arthritis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

3.  Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise.

Authors:  P W Bodell; E Kodesh; F Haddad; F P Zaldivar; D M Cooper; G R Adams
Journal:  J Appl Physiol (1985)       Date:  2008-12-04

4.  Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis.

Authors:  Youn-Soo Hahn; Joong-Gon Kim
Journal:  Korean J Pediatr       Date:  2010-11-30

5.  Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.

Authors:  Patrick H Dessein; Barry I Joffe; Sham Singh
Journal:  Arthritis Res Ther       Date:  2005-03-24       Impact factor: 5.156

Review 6.  Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.

Authors:  Katherine Anne B Marzan
Journal:  Adolesc Health Med Ther       Date:  2012-06-20

7.  Low Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic Arthritis.

Authors:  Anna-Carin Lundell; Malin Erlandsson; Maria Bokarewa; Hille Liivamägi; Karin Uibo; Sirje Tarraste; Tiina Rebane; Tiina Talvik; Chris Pruunsild; Rille Pullerits
Journal:  J Immunol Res       Date:  2018-11-28       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.